Your browser doesn't support javascript.
loading
The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART.
Haidari, G; Day, Suzanne; Wood, M; Ridgers, H; Cope, Alethea V; Fleck, Sue; Yan, Celine; Reijonen, Kalevi; Hannaman, Drew; Spentzou, Aggeliki; Hayes, Peter; Vogt, A; Combadiere, Behazine; Cook, Adrian; McCormack, Sheena; Shattock, Robin J.
Afiliación
  • Haidari G; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Day S; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Wood M; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Ridgers H; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Cope AV; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Fleck S; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Yan C; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Reijonen K; FIT Biotech Ltd., Tampere, Finland.
  • Hannaman D; Ichor Medical Systems Inc, San Diego, CA, United States.
  • Spentzou A; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
  • Hayes P; Human Immunology Laboratory, International AIDS Vaccine Initiative, Imperial College London, London, United Kingdom.
  • Vogt A; Department of Dermatology and Allergy, Clinical Research Center for Hair and Skin Science, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Combadiere B; Sorbonne Université, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), INSERM U1135, Paris, France.
  • Cook A; Medical Research Council Clinical Trials Unit at UCL, University College London, London, United Kingdom.
  • McCormack S; Medical Research Council Clinical Trials Unit at UCL, University College London, London, United Kingdom.
  • Shattock RJ; Group of Mucosal Infection and Immunity, Department of Medicine, Imperial College London, London, United Kingdom.
Front Immunol ; 10: 2911, 2019.
Article en En | MEDLINE | ID: mdl-31921170
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Vacunas contra el SIDA / Vacunas de ADN / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Vacunas contra el SIDA / Vacunas de ADN / Inmunogenicidad Vacunal Tipo de estudio: Clinical_trials Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article